Erratum: Urinary BPA and phthalate metabolite concentrations and plasma vitamin d levels in pregnant women: A repeated measures analysis (Environ Health Perspect, (2017) 125, 8, 087026, 10.1289/EHP1178);Urinary BPA and phthalate metabolite concentrations and plasma vitamin D levels in pregnant women: A repeated measures analysis

Environmental Health Perspectives

Volumn 125, Issue 8, 2017, Pages

  Johns, Lauren E ^a   Ferguson, Kelly K ^a,b   Cantonwine, David E ^c   McElrath, Thomas F ^c   Mukherjee, Bhramar ^a   Meeker, John D ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CALCIFEDIOL; DRUG METABOLITE; ENDOCRINE DISRUPTOR; MONO 3 CARBOXYPROPYL PHTHALATE; MONO N BUTYL PHTHALATE; MONO(2 ETHYL 5 CARBOXYPENTYL) PHTHALATE; MONO(2 ETHYL 5 HYDROXYHEXYL) PHTHALATE; MONO(2 ETHYL 5 OXOHEXYL) PHTHALATE; MONO(3 CARBOXYPROPYL) PHTHALATE; MONOBENZYL PHTHALATE; MONOETHYL PHTHALATE; MONOISOBUTYL PHTHALATE; PHTHALIC ACID; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; UNCLASSIFIED DRUG; VITAMIN D; BENZHYDRYL DERIVATIVE; PHENOL DERIVATIVE; PHTHALIC ACID DERIVATIVE; POLLUTANT;

ADULT; ARTICLE; BODY MASS; CHEMILUMINESCENCE IMMUNOASSAY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DRUG CONCENTRATION; DRUG SENSITIVITY; ENVIRONMENTAL EXPOSURE; FEMALE; GESTATIONAL AGE; GESTATIONAL WEIGHT GAIN; HEALTH INSURANCE; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MATERNAL AGE; MOLECULAR WEIGHT; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SOCIAL STATUS; STATISTICAL ANALYSIS; VITAMIN D DEFICIENCY; VITAMIN INTAKE; YOUNG ADULT; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED; MASSACHUSETTS; MATERNAL EXPOSURE; POLLUTANT; PREGNANCY; STATISTICS AND NUMERICAL DATA; URINE;

ADULT; BENZHYDRYL COMPOUNDS; BOSTON; CASE-CONTROL STUDIES; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MATERNAL EXPOSURE; PHENOLS; PHTHALIC ACIDS; PREGNANCY; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 85031721330     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/EHP4855     Document Type: Erratum

References (72)

1. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. 2013. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 346:f1169, PMID: 23533188.
2. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192-200, PMID: 15687057.
3. Bikle DD. 2014. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319-329, https://doi.org/10.1016/j.chembiol.2013.12.016.
4. Bodnar LM, Platt RW, Simhan HN. 2015. Early-pregnancy vitamin D deficiency and risk of preterm birth subtypes. Obstet Gynecol 125:439-447, https://doi.org/10. 1097/AOG.0000000000000621.
5. Bodnar LM, Simhan HN. 2010. Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet Gynecol Surv 65:273-284, PMID: 20403218, https://doi.org/10.1097/OGX.0b013e3181dbc55b.
6. Burris HH, Thomas A, Zera CA, McElrath TF. 2015. Prenatal vitamin use and vitamin D status during pregnancy, differences by race and overweight status. J Perinatol 35:241-245, PMID: 25357099, https://doi.org/10.1038/jp.2014.198.
7. Burris HH, Van Marter LJ, McElrath TF, Tabatabai P, Litonjua AA, Weiss ST, et al. 2014. Vitamin D status among preterm and full-term infants at birth. Pediatr Res 75:75-80, PMID: 24121425, https://doi.org/10.1038/pr.2013.174.
8. Calvo MS, Whiting SJ, Barton CN. 2004. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 80:1710S-1716S.
9. Cantonwine DE, Cordero JF, Rivera-Gonzalez LO, Anzalota Del Toro LV, Ferguson KK, Mukherjee B, et al. 2014. Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictors. Environ Int 62:1-11, PMID: 24161445, https://doi.org/10. 1016/j.envint.2013.09.014.
10. Carlberg C. 2014. Genome-wide (over)view on the actions of vitamin D. Front Physiol 5:167, PMID: 24808867, https://doi.org/10.3389/fphys.2014.00167.
11. Casas L, Fernandez MF, Llop S, Guxens M, Ballester F, Olea N et al. 2011. Urinary concentrations of phthalates and phenols in a population of Spanish pregnant women and children. Environ Int 37:858-866, https://doi.org/10.1016/j.envint. 2011.02.012.
12. Ersfeld DL, Rao DS, Body JJ, Sackrison JL, Jr., Miller AB, Parikh N, et al. 2004. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 37:867-874, https://doi.org/10.1016/j.clinbiochem.2004. 06.006.
13. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. 2012. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 58:531-542, PMID: 22230812, https://doi.org/10.1373/clinchem.2011.172155.
14. Ferguson KK, Colacino JA, Lewis RC, Meeker JD. 2016. Personal care product use among adults in NHANES: associations between urinary phthalate metabolites and phenols and use of mouthwash and sunscreen. J Expo Sci Environ Epidemiol 27(3):326-332, PMID: 27168391, https://doi.org/10.1038/jes.2016.27.
15. Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. 2015. Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: a repeated measures analysis. Environ Health Perspect 123:210-216, PMID: 25402001, https://doi.org/10.1289/ehp.1307996.
16. Ferguson KK, McElrath TF, Ko YA, Mukherjee B, Meeker JD. 2014a. Variability in urinary phthalate metabolite levels across pregnancy and sensitive windows of exposure for the risk of preterm birth. Environ Int 70:118-124.
17. Ferguson KK, McElrath TF, Meeker JD. 2014b. Environmental phthalate exposure and preterm birth. JAMA Pediatr 168:61-67.
18. Grundmann M, von Versen HF. 2011. Vitamin D-roles in women's reproductive health? Reprod Biol Endocrinol 9:146, PMID: 22047005, https://doi.org/10.1186/ 1477-7827-9-146.
19. Hall LM, Kimlin MG, Aronov PA, Hammock BD, Slusser JR, Woodhouse LR, et al. 2010. Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 140:542-550, PMID: 20053937, https://doi.org/10.3945/jn.109.115253.
20. Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, et al. 2013. Molecular mechanisms of vitamin D action. Calcif Tissue Int 92:77-98, PMID: 22782502, https://doi.org/10.1007/s00223-012-9619-0.
21. Henry HL. 2011. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 25:531-541, https://doi.org/10.1016/j.beem.2011.05.003.
22. Holick MF. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678S-1688S.
23. Holick MF. 2007. Vitamin D deficiency. N Engl J Med 357:266-281, https://doi.org/ 10.1056/NEJMra070553.
24. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. 2011. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911-1930, PMID: 21646368, https://doi.org/10.1210/jc.2011-0385.
25. Holick MF, Chen TC. 2008. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S-1086S.
26. Hollis BW. 2010. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am 39:271-286, table of contents, https://doi.org/10.1016Zj.ecl.2010. 02.012.
27. Hong EJ, Ji YK, Choi KC, Manabe N, Jeung EB. 2005. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k. J Reprod Dev 51:253-263, PMID: 15883486.
28. Hornung JP, Fritschy JM, Tork I. 1990. Distribution of two morphologically distinct subsets of serotoninergic axons in the cerebral cortex of the marmoset. J Comp Neurol 297:165-181, PMID: 2115053, https://doi.org/10.1002/cne.902970202.
29. Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. 2007. Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod 22:2715-2722, PMID: 17704099, https://doi.org/10.1093/humrep/dem205.
30. Johns LE, Ferguson KK, McElrath TF, Mukherjee B, Meeker JD. 2016a. Associations between Repeated Measures of Maternal Urinary Phthalate Metabolites and Thyroid Hormone Parameters during Pregnancy. Environ Health Perspect 124(11):1808-1815, PMID: 27152641, https://doi.org/10.1289/EHP170.
31. Johns LE, Ferguson KK, Meeker JD. 2016b. Relationships between urinary phthalate metabolite and bisphenol a concentrations and vitamin d levels in U.S. adults: National Health and Nutrition Examination Survey (NHANES), 2005-2010. J Clin Endocrinol Metab 101(11):4062-4069, PMID: 27648964, https://doi.org/10.1210/jc. 2016-2134.
32. Johns LE, Ferguson KK, Soldin OP, Cantonwine DE, Rivera-Gonzalez LO, Del Toro LV, et al. 2015. Urinary phthalate metabolites in relation to maternal serum thyroid and sex hormone levels during pregnancy: a longitudinal analysis. Reprod Biol Endocrinol 13:4, PMID:25596636, https://doi.org/10.1186/1477-7827-13-4.
33. Johnson SA, Painter MS, Javurek AB, Ellersieck MR, Wiedmeyer CE, Thyfault JP, et al. 2015. Sex-dependent effects of developmental exposure to bisphenol A and ethinyl estradiol on metabolic parameters and voluntary physical activity. J Dev Orig Health Dis 6(6):539-552, PMID: 26378919, https://doi.org/10.1017/ S2040174415001488.
34. Kim S, An BS, Yang H, Jeung EB. 2013. Effectsofoctylphenoland bisphenol Aon the expression ofcalcium transport genes in the mouse duodenum and kidney during pregnancy. Toxicology 303:99-106, https://doi.org/10.1016/jtox.2012.10.023.
35. Lewis RC, Meeker JD, Peterson KE, Lee JM, Pace GG, Cantaral A, et al. 2013. Predictors of urinary bisphenol A and phthalate metabolite concentrations in Mexican children. Chemosphere 93:2390-2398, PMID: 24041567, https://doi.org/ 10.1016/j.chemosphere.2013.08.038.
36. Liu C, Zhao L, Wei L, Li L. 2015. DEHP reduces thyroid hormones via interacting with hormone synthesis-related proteins, deiodinases, transthyretin, receptors, and hepatic enzymes in rats. Environ Sci Pollut Res Int 22:12711-12719, PMID: 25913319, https://doi.org/10.1007/s11356-015-4567-7.
37. Liu NQ, Kaplan AT, Lagishetty V, Ouyang YB, Ouyang Y, Simmons CF, et al. 2011. Vitamin D and the regulation of placental inflammation. J Immunol 186:5968-5974, PMID: 21482732, https://doi.org/10.4049/jimmunol.1003332.
38. Lucas R, Xiang F, Ponsonby AL. 2013. Vitamin D sufficiency in pregnancy. BMJ 346: f1675, PMID: 23533189.
39. Luk J, Torrealday S, Neal Perry G, Pal L. 2012. Relevance of vitamin D in reproduction. Hum Reprod 27:3015-3027, PMID: 22824625, https://doi.org/10.1093/humrep/ des248.
40. Ma R, Gu Y, Zhao S, Sun J, Groome LJ, Wang Y. 2012. Expressions of vitamin Dmet-abolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies. Am J Physiol Endocrinol Metab 303: E928-E935,PMID: 22871339, https://doi.org/10.1152/ajpendo.00279.2012.
41. Mathieu-Denoncourt J, Wallace SJ, de Solla SR, Langlois VS. 2015. Plasticizer endocrine disruption: Highlighting developmental and reproductive effects in mammals and non-mammalian aquatic species. Gen Comp Endocrinol 219:7488, PMID: 25448254, https://doi.org/10.1016Zj.ygcen.2014.11.003.
42. McElrath TF, Lim K-H, Pare E, Rich-Edwards J, Pucci D, Troisi R, et al. 2012. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol 207:407 e1-e7, https://doi.org/10.1016/j.ajog.2012.08.010.
43. Meeker JD, Calafat AM, Hauser R. 2009a. Urinary metabolites of di(2-ethylhexyl) phthalate are associated with decreased steroid hormone levels in adult men. J Androl 30:287-297.
44. Meeker JD, Sathyanarayana S, Swan SH. 2009b. Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos Trans R Soc Lond B Biol Sci 364:2097-2113.
45. Moon RJ, Crozier SR, Dennison EM, Davies JH, Robinson SM, Inskip HM, et al. 2015. Tracking of 25-hydroxyvitamin D status during pregnancy: the importance of vitamin D supplementation. Am J Clin Nutr 102:1081-1087, https://doi.org/10. 3945/ajcn.115.115295.
46. Mortensen ME, Calafat AM, Ye X, Wong L-Y, Wright DJ, Pirkle JL, et al. 2014. Urinary concentrations of environmental phenols in pregnant women in a pilot study of the National Children's Study. Environ Res 129:32-38, https://doi.org/ 10.1016/j.envres.2013.12.004.
47. Mu D, Gao F, Fan Z, Shen H, Peng H, Hu J. 2015. Levels of phthalate metabolites in urine of pregnant women and risk of clinical pregnancy loss. Environ Sci Technol 49:10651-10657, PMID: 26251123, https://doi.org/10.1021/acs.est.5b02617.
48. Murthi P, Yong HE, Ngyuen TP, Ellery S, Singh H, Rahman R, et al. 2016. Role of the placental vitamin D receptor in modulating feto-placental growth in fetal growth restriction and preeclampsia-affected pregnancies. Front Physiol 7:43, PMID: 26924988, https://doi.org/10.3389/fphys.2016.00043.
49. Nguyen TP, Yong HE, Chollangi T, Borg AJ, Brennecke SP, Murthi P. 2015. Placental vitamin D receptor expression is decreased in human idiopathic fetal growth restriction. J Mol Med (Berl) 93:795-805, PMID: 25716068, https://doi.org/10.1007/ s00109-015-1267-1.
50. Norman AW. 2008. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88:491S-499S, PMID: 18689389.
51. Otsuka H, Sugimoto M, Ikeda S, Kume S. 2012. Effects of bisphenol A administration to pregnant mice on serum Ca and intestinal Ca absorption. Anim Sci J 83:232-237, PMID: 22435627, https://doi.org/10.111Vj.1740-0929.2011. 00947.x.
52. Perez-Lopez FR. 2007. Vitamin D: the secosteroid hormone and human reproduction. Gynecol Endocrinol 23:13-24, https://doi.org/10.1080/09513590601045629.
53. Perrier F, Giorgis-Allemand L, Slama R, Philippat C. 2016. Within-subject pooling of biological samples to reduce exposure misclassification in biomarker-based studies. Epidemiology 27:378-388, PMID: 27035688, https://doi.org/10.1097/EDE. 0000000000000460.
54. Philippat C, Bennett D, Calafat AM, Picciotto IH. 2015. Exposure to select phthalates and phenols through use of personal care products among Californian adults and their children. Environ Res 140:369-376, PMID: 25929801, https://doi.org/10. 1016/j.envres.2015.04.009.
55. Pike JW, Meyer MB. 2010. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 39:255-269, table of contents, https://doi.org/10.1016/j.ecl. 2010.02.007.
56. Ponsonby AL, Lucas RM, Lewis S, Halliday J. 2010. Vitamin D status during pregnancy and aspects of offspring health. Nutrients 2:389-407, PMID: 22254029, https://doi.org/10.3390/nu2030389.
57. Quesnot N, Bucher S, Fromenty B, Robin MA. 2014. Modulation of metabolizing enzymes by bisphenol A in human and animal models. Chem Res Toxicol 27:1463-1473, https://doi.org/10.1021/tx500087p.
58. Richardson DB, Rzehak P, Klenk J, Weiland SK. 2007. Analyses of case-control data for additional outcomes. Epidemiology 18:441-445, https://doi.org/10.1097/ EDE.0b013e318060d25c.
59. Robinson CJ, Wagner CL, Hollis BW, Baatz JE, Johnson DD. 2011. Maternal vitamin D and fetal growth in early-onset severe preeclampsia. Am J Obstet Gynecol 204:556, e551-e554, https://doi.org/10.1016/j.ajog.2011.03.022.
60. Rosen CJ, Adams JS, Bickle DD, Black DM, Demay MB, Manson JE, et al. 2012. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33:456-492, https://doi.org/10.1210/er.2012-1000.
61. Sathyanarayana S, Barrett E, Butts S, Wang C, Swan SH. 2014. Phthalate exposure and reproductive hormone concentrations in pregnancy. Reproduction 147:401-409, PMID: 24196015, https://doi.org/10.1530/REP-13-0415.
62. Schmitt EE, Vellers HL, Porter WW, Lightfoot JT. 2016. Environmental endocrine disruptor affects voluntary physical activity in mice. Med Sci Sports Exerc 48:1251-1258, PMID: 26895396, https://doi.org/10.1249/MSS. 0000000000000908.
63. Sekaran S, Jagadeesan A. 2015. In utero exposure to phthalate downregulates critical genes in Leydig cells of F1 male progeny. J Cell Biochem 116:14661477, PMID: 25649163, https://doi.org/10.1002/jcb.25108.
64. Serrano SE, Braun J, Trasande L, Dills R, Sathyanarayana S. 2014. Phthalates and diet: a review of the food monitoring and epidemiology data. Environ Health 13:43, PMID: 24894065, https://doi.org/10.1186/1476-069X-13-43.
65. Song Y, Hauser R, Hu FB, Franke AA, Liu S, Sun Q. 2014. Urinary concentrations of bisphenol A and phthalate metabolites and weight change: a prospective investigation in US women. Int J Obes Relat Metab Disord 38:1532-1537, https://doi.org/10.1038/ijo.2014.63.
66. Thacher TD, Clarke BL. 2011. Vitamin D insufficiency. Mayo Clin Proc 86:50-60, PMID: 21193656, https://doi.org/10.4065/mcp.2010.0567.
67. Thorne-Lyman A, Fawzi WW. 2012. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol 26 (suppl 1):75-90, PMID: 22742603, https://doi.org/ 10.1111/j.1365-3016.2012.01283.x.
68. Urrutia RP, Thorp JM. 2012. Vitamin D in pregnancy: current concepts. Curr Opin Obstet Gynecol 24:57-64, PMID: 22327734, https://doi.org/10.1097/GCO.0b013e3283505ab3.
69. Wagner D, Hanwell HE, Vieth R. 2009. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 42:1549-1556, PMID: 19631201, https://doi.org/10.1016/j.clinbiochem.2009.07.013.
70. Wei SQ. 2014. Vitamin D and pregnancy outcomes. Curr Opin Obstet Gynecol 26:438-447, PMID: 25310531, https://doi.org/10.1097/GCO.0000000000000117.
71. Woolcott CG, Giguere Y, Weiler HA, Spencer A, Forest JC, Armson BA, et al. 2016. Determinants of vitamin D status in pregnant women and neonates. Can J Public Health 107:e410-e416, PMID: 28026707.
72. Wormuth M, Scheringer M, Vollenweider M, Hungerbiihler K. 2006. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans?. Risk Anal 26:803-824, PMID: 16834635, https://doi.org/10.1111/]. 1539-6924.2006.00770.x.